Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24947 | 247 | 31.1 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
876 | 10798 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//ABCG2 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CIAPIN1 | Author keyword | 45 | 90% | 8% | 19 |
2 | NOB1 | Author keyword | 45 | 90% | 8% | 19 |
3 | MG7 AG | Author keyword | 14 | 100% | 3% | 7 |
4 | ZNRD1 | Author keyword | 13 | 71% | 4% | 10 |
5 | ANAMORSIN | Author keyword | 12 | 86% | 2% | 6 |
6 | EMILIN1 | Author keyword | 6 | 71% | 2% | 5 |
7 | ONCOL SPERIMENTALE 2 | Address | 4 | 30% | 4% | 10 |
8 | EMILIN | Author keyword | 3 | 50% | 2% | 5 |
9 | ZINC RIBBON MOTIF | Author keyword | 3 | 100% | 1% | 3 |
10 | EMILIN 1 | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CIAPIN1 | 45 | 90% | 8% | 19 | Search CIAPIN1 | Search CIAPIN1 |
2 | NOB1 | 45 | 90% | 8% | 19 | Search NOB1 | Search NOB1 |
3 | MG7 AG | 14 | 100% | 3% | 7 | Search MG7+AG | Search MG7+AG |
4 | ZNRD1 | 13 | 71% | 4% | 10 | Search ZNRD1 | Search ZNRD1 |
5 | ANAMORSIN | 12 | 86% | 2% | 6 | Search ANAMORSIN | Search ANAMORSIN |
6 | EMILIN1 | 6 | 71% | 2% | 5 | Search EMILIN1 | Search EMILIN1 |
7 | EMILIN | 3 | 50% | 2% | 5 | Search EMILIN | Search EMILIN |
8 | ZINC RIBBON MOTIF | 3 | 100% | 1% | 3 | Search ZINC+RIBBON+MOTIF | Search ZINC+RIBBON+MOTIF |
9 | EMILIN 1 | 2 | 67% | 1% | 2 | Search EMILIN+1 | Search EMILIN+1 |
10 | EMILINS | 2 | 67% | 1% | 2 | Search EMILINS | Search EMILINS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ZINC RIBBON DOMAIN CONTAINING 1 | 17 | 100% | 3% | 8 |
2 | ANAMORSIN | 11 | 100% | 2% | 6 |
3 | CIAPIN1 | 9 | 83% | 2% | 5 |
4 | ZNRD1 | 9 | 83% | 2% | 5 |
5 | ZNRD1 GENE | 8 | 100% | 2% | 5 |
6 | ANTIAPOPTOTIC MOLECULE ANAMORSIN | 6 | 100% | 2% | 4 |
7 | TFIIS ZINC RIBBON | 5 | 63% | 2% | 5 |
8 | MDR 1 | 2 | 23% | 4% | 9 |
9 | DRE2 | 2 | 67% | 1% | 2 |
10 | NOB1 | 2 | 50% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
CIAPIN1 as a therapeutic target in cancer | 2010 | 15 | 31 | 32% |
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches | 2014 | 14 | 70 | 4% |
Multidrug resistance in gastric cancer: Recent research advances and ongoing therapeutic challenges | 2007 | 40 | 75 | 11% |
The diagnostic value of monoclonal gastric cancer 7 antigen: a systematic review with meta-analysis | 2014 | 1 | 19 | 21% |
MG7 mimotope-based DNA vaccination for gastric cancer | 2006 | 1 | 79 | 16% |
Overcome Cancer Cell Drug Resistance Using Natural Products | 2015 | 0 | 24 | 13% |
Cancer mucosa antigens: novel immunotherapeutic targets | 2008 | 1 | 49 | 12% |
Molecular basis of therapeutic approaches to gastric cancer | 2009 | 31 | 41 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONCOL SPERIMENTALE 2 | 4 | 30% | 4.0% | 10 |
2 | QINDU STOMATOL | 1 | 33% | 1.2% | 3 |
3 | STATE TUMOR BIOL | 1 | 25% | 1.2% | 3 |
4 | CANC EPIDEMIOL CARCINOGENESIS TRAN | 1 | 50% | 0.4% | 1 |
5 | DIGEST DIS 1 | 1 | 50% | 0.4% | 1 |
6 | ECCELLENZA MATI | 1 | 50% | 0.4% | 1 |
7 | IGM IOR | 1 | 50% | 0.4% | 1 |
8 | MICROGRAV AGEING TRAINING IMMOBIL EXCELLENC | 1 | 50% | 0.4% | 1 |
9 | MOL CELL BIOLSAMSUNG BIOMED | 1 | 50% | 0.4% | 1 |
10 | RICU | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000132622 | DARPP 32//PPP1R1B//ARPP 21 |
2 | 0.0000065485 | GRP PEPTIDE CHEM//BRANCHED POLYPEPTIDES//HUNGARIAN SCI PEPTIDE CHEM GRP |
3 | 0.0000065366 | IMMUNO PCR//LEHRSTUHL BIOL CHEM MIKROSTRUKTURTECH//REAL TIME IMMUNO PCR |
4 | 0.0000059317 | MARFAN SYNDROME//FIBRILLIN//FBN1 |
5 | 0.0000055563 | CYSTEINE DESULFURASE//ISCU//ZYTOBIOL ZYTOPATHOL |
6 | 0.0000049276 | TNFAIP1//KCTD7//KCTD10 |
7 | 0.0000047638 | MOL IMMUNOL RUMENTAT//GENOMIC MATCHING TECHNIQUE//HLA A ALLELES |
8 | 0.0000047065 | FIBULIN 1//EFEMP1//FIBULIN 3 |
9 | 0.0000045860 | SNORNA//SMALL NUCLEOLAR RNAS//PRE RRNA PROCESSING |
10 | 0.0000043321 | L1210 CELL LINE//TCRP1//MOL PHYSIOL GENET |